Research Progress of 161Tb-PSMA Radioligand Therapy for Prostate Cancer
Prostate specific membrane antigen (PSMA) radioligand therapy (PRLT) has become an important new therapy，especially suitable for the treatment of metastatic castration resistant prostate cancer (mCRPC) which cannot be effectively controlled by conventional therapy. PRLT，represented by Lutetium-177 (...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Board of Journal of Isotopes
2024-10-01
|
| Series: | Journal of Isotopes |
| Subjects: | |
| Online Access: | https://tws.xml-journal.net/article/doi/10.7538/tws.2024.youxian.058 |